Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jeffrey A. Meckler | Chief Executive Officer | 2025-07-27 | 6,068 | $8.30 | $50.38kBuy |
Jeffrey A. Meckler | CEO and Director | 2024-11-25 | 42,553 | $1.18 | $50.00kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Dexcel Pharma Technologies Ltd | 382.72% | 4,234,897 | $9.66M | Insider |
Michael James Newman | 123.66% | 1,368,356 | $3.12M | Insider |
Glen R. Anderson | 117.87% | 1,304,318 | $2.97M | Insider |
John W. Kozarich | 13.72% | 151,761 | $346.02k | Insider |
Anthony J. Maddaluna | 4.84% | 53,570 | $122.14k | Insider |
Nadav Navon | 1.76% | 19,456 | $44.36k | Insider |
Jeffrey A. Meckler | 1.20% | 13,312 | $30.35k | Insider |
Gil Bianco | 0.90% | 10,000 | $22.80k | Insider |
Issac Silberman | 0.36% | 4,000 | $9.12k | Insider |
Boyan Vesselinov Litchev | 0.10% | 1,150 | $2.62k | Insider |